Moderna and Pfizer-BioNTech vaccines prime T cells to fight SARS-CoV-2 variants
LJI researchers highlight the importance of T cell cross reactivity in stopping severe COVID-19 cases
LJI researchers highlight the importance of T cell cross reactivity in stopping severe COVID-19 cases
Study compares four vaccines and natural immunity
New mouse models may shed light on the puzzling aspects of SARS-CoV-2 infection
New LJI review shows how T cells target more than 1,400 sites on SARS-CoV-2
Erica Ollman Saphire brings together scientific competitors to find new antibody therapeutics for COVID-19.
Men and women have different immune systems. With a better understanding of sex-specific immune differences, scientists can more effectively fight infections, cancers, heart disease, and even pregnancy complications.
San Diego biotech entrepreneurs François Ferré, Ph.D., and Magda Marquet, Ph.D., knew supporting LJI would be critical for advancing our understanding of COVID-19.
The bioinformatics tools Dr. Peters has developed are invaluable for immunologists worldwide.
Reactions reflect unique features of an individual’s immune system, not the strength of a response
Antibodies can change to counter new forms of the shape-shifting virus, research hints